Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
LQR House Q2 FY26 swings to net income of $2.7 million; revenue falls 31% to $345,975 from year-ago quarter

LQR House Q2 FY26 swings to net income of $2.7 million; revenue falls 31% to $345,975 from year-ago quarter

ReutersReuters2026/08/19 20:07
  • LQR House posted net income of USD 2.7 million in Q2 2026, swinging from a net loss a year earlier.
  • Revenue fell 31% to USD 345,975, led by a 37% drop in product revenue to USD 304,416.
  • Operating loss narrowed 45% to USD 1.22 million as general and administrative expense declined 43% to USD 1.26 million.
  • Other income rose to USD 3.92 million, driven by a USD 4.21 million gain tied to Fusion Five remeasurement.
  • Fusion Five added brokerage revenue of USD 37,778 following the June 1 acquisition of a controlling 54% stake.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LQR House Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-091661), on August 19, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas